Vermillion, Inc. (VRML) News
Filter VRML News Items
VRML News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest VRML News From Around the Web
Below are the latest news stories about Vermillion Inc that investors may wish to consider to help them evaluate VRML as an investment opportunity.
Vermillion changes its name to Aspira Women’s Health Inc.Vermillion (VRML) has changed its name to Aspira Women’s Health, effective today and will trade on the Nasdaq Stock Market under the new ticker symbol “AWH” and a new CUSIP (04537Y109), effective June 12. Valerie Palmieri, President, and Chief Executive Officer of Aspira Women’s Health said, “Our new company name... |
Vermillion, Inc. Announces Rebranding and Company Name Change to Aspira Women’s Health Inc.Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on ovarian cancer risk assessment, today announced a major rebranding to reflect the company’s continuing evolution towards becoming a comprehensive gynecologic health company, including a corporate name change to Aspira Women’s Health Inc effective today, June 11, 2020. The company’s common stock will trade on the Nasdaq Stock Market under the new ticker symbol “AWH” effective June 12, 2020. |
Vermillion set to roll out COVID-19 test and new cancer biomarkersVermillion (VRML) subsidiary ASPIRA Labs has finished validating Roche's Elecsys Anti-SARS-CoV-2 antibody blood test in addition to several new oncology biomarkers.The Roche assay demonstrated 100.0% sensitivity and 99.8% specificity.ASPIRA plans to offer the assay and additional pelvic mass risk assessment biomarkers by month-end in conjunction with its proprietary OVA1 plus... |
Why Vermillion's Stock Is Trading Higher TodayVermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including coronavirus antibody testings.The company is also expected to join the Russell 3000 Index on June 29.Vermillion is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices. Geographically all the operations are functioned from the region of U.S.Vermil... |
Vermillion Completes Validation of New Pre-Surgical Test Offerings with OVA1®plus, including COVID-19 Antibody Testing and Additional Pelvic Mass Risk Assessment BiomarkersAUSTIN, Texas, June 10, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its. |
Vermillion to join Russell 3000Vermillion (VRML) will join the Russell 3000 Index after the conclusion of its annual reconstitution after the close on Monday, June 29.... |
Vermillion joins Russell 3000 IndexVermillion (VRML) joins the broad-market Russell 3000® Index, effective after the market opens on June 29, 2020. “We are thrilled to join the Russell 3000®, which we believe will attract broader interest in Vermillion from institutional investors and investment funds,” said Valerie Palmieri, CEO.... |
Vermillion Set to Join Russell 3000® IndexVermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US stock market opens on June 29, 2020, according to a preliminary list of additions posted on June 5, 2020. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 8, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. |
Do Hedge Funds Love Vermillion, Inc. (VRML)?The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […] |
Edited Transcript of VRML earnings conference call or presentation 14-May-20 8:30pm GMTQ1 2020 Vermillion Inc Earnings Call |